Pulmonary Hypertension

The UCSF Pulmonary Hypertension Program was established over 30 years ago, and has been designated as a Pulmonary Hypertension Comprehensive Care Center by the Pulmonary Hypertension Association for the evaluation and treatment of the disorder. With more than 700 patients with pulmonary hypertension from all etiologies and over 450 patients with pulmonary arterial hypertension, our program offers the full spectrum of care ranging from oral, inhalational and catheter-based therapies to experimental therapies (including graded balloon atrial septstomy with stent), extracorporeal support (ECMO) as a bridge to pharmacotherapies  or surgery and lung transplantation. The UCSF Lung Transplantation Program performs over 40-50 lung transplants yearly with the best outcomes in the nation. A team of physicians, nurse coordinators, nurse practitioners, pharmacists and social workers – dedicated to education as well as approved, state-of-the-art pharmacologic and surgical therapies– creates patient-centered, individualized management strategies that optimize care and help patients better manage their condition.